Walgreens improving pharmacy business and comments from the company’s CEO are convincing Wall Street that the drugstore won't ...

Belk says corporate employees will return to in-person work three days a week at the company's headquarters on Tyvola Road in southwest Charlotte. It marks a shift from the fully ...

Walgreens Boots (NASDAQ:WBA) fell 6.6% on a report that a potential takeover by private equity from Sycamore Partners is likely not going to happen. "It's mostly dead," CNBC's David Faber said on ...

Walgreens Boots Alliance Inc.’s chairman and biggest shareholder, Stefano Pessina, has dealmaking in his DNA. Yet finding a ...

A Wall Street Journal report noted that according to CNBC's David Faber, a prospective deal between Walgreens and New York ...

The Wall Street Journal previously reported that Walgreens and Sycamore Partners were discussing a deal that could be finalized early this year.

Private equity firm Sycamore Partners has been speaking with private credit firms about debt financing for a potential Walgreens deal, according to people familiar with the matter, despite an ...

Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In fact, according to reporting from Bloomberg and The Financial Times in 2019, ...

Analyst Michael Cherny of Leerink Partners reiterated a Hold rating on Walgreens Boots Alliance (WBA – Research Report), retaining the price ...

Shares of Walgreens Boots Alliance (WBA) are down about 3% to $11.49 in early trading after CNBC’s David Faber said on-air that his sources ...

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.